Navigation Links
Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder
Date:3/22/2012

FORT WORTH, Texas, March 22, 2012 /PRNewswire/ -- The Board of Directors of Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leading innovator in advanced wound care solutions, announced today that Robert Lutz, Jr. has been appointed to the Board of Directors of the Company.  In addition, Scott A. Haire has resigned as Chairman of the Board of Directors and as Chief Executive Officer of the Company, and Deborah Jenkins Hutchinson has resigned as President of the Company, and Mr. Lutz has been elected as the new Chairman of the Board, Chief Executive Officer and President of the Company.  Mr. Haire and Ms Jenkins Hutchinson will continue on as directors of the Company.

Mr. Lutz has extensive management and leadership experience with both public and private companies, including subsidiaries of Liberty Corp, American Express and AMRESCO.  Mr. Lutz brings a proven track record in significantly growing the revenue and net income of companies, and has significant experience in negotiating business contracts with Fortune 100 firms, including IBM and AT&T. 

In conjunction with Mr. Lutz joining Wound Management, the Company has reacquired the North American distribution rights for its CellerateRX® advanced wound care powder from Juventas, LLC.  By doing so, Wound Management will be able to create a unified sales and distribution program for CellerateRX and its other products.  This reacquisition includes the acquisition of a newly-packaged specialized CellerateRX powder kit for use in the biologic surgical closure market that was successfully established by Juventas.  As a result, the management agreement between Wound Management and Juventas previously announced in November 2011 has also been terminated, and Juventas is no longer involved with Wound Management.

"After extensive due diligence with Wound Management and its core subsidiary, Wound Care Innovations, LLC, I am very impressed
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
2. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
3. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
4. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
5. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
6. Wound Management Technologies, Inc. Announces Evidence Based Study
7. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
8. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
9. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
10. New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
11. Glycotex Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- Top Staten Island Pediatrician ... his feedback on article, which discusses tips for parents about ... According to US News ... death among American children aged 1 to 4, and can ... One expert in the article says that watching a ...
(Date:7/23/2014)... July 23, 2014 Inovio Pharmaceuticals, ... results from its randomized, double-blind, placebo-controlled phase ... biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated ... 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific immunotherapy, ... CIN1 or no disease, meeting the study,s ...
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
Breaking Medicine Technology:Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... , PALO ALTO, Calif., Dec. 2 ... 25, 2009, Varian, Inc. filed with the U.S. Securities and Exchange ... ended October 2, 2009. This Annual Report may be accessed ... and "SEC Filings," and then on "10-K" in the table shown. ...
... , ST. LOUIS, Dec. 2 KV Pharmaceutical Company ... an employment agreement with Interim President and Chief Executive Officer ... 2011. Mr. Van Vliet has served as Interim President and ... provides continuity of senior leadership as the Company seeks to ...
Cached Medicine Technology:KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2
(Date:7/23/2014)... ( FXS ) is a genetic disorder that causes ... autistic spectrum, as well as cognitive deficits. It is ... the most common cause of autism. , Now biomedical ... a study that sheds light on the ... (July 23) in the Journal of Neuroscience , ...
(Date:7/23/2014)... Kathleen Doheny HealthDay Reporter ... surgery appears to have an additional side benefit -- ... to a new study. The study found that ... reported having incontinence prior to the procedure. After surgery, ... improved or disappeared, said study researcher Dr. Leslee Subak, ...
(Date:7/23/2014)... the genome resulting from a combination of genetic modifications ... weak predispositions to developing certain kinds of cancer; in ... throughout our lifetime. Although the genetic origins of cancers ... not able to measure the role of non-coding regions ... from the University of Geneva (UNIGE), by studying tissues ...
(Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new collection of ... a promotion of wedding dresses. According to a representative ... end of this month. , The beautiful wedding dresses ... mermaid, ball-gown, empire, and more. Agebc.com is a well-known ... for women, and the company is devoted to providing ...
Breaking Medicine News(10 mins):Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:Genetics of cancer: Non-coding DNA can finally be decoded 2Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... ... beings need music as a form of release and expression, and now it has been ... ... stressors, stimuli, and distractions in this world, it can be difficult for the average person ...
... Huge ... ... Almac has addressed ongoing industry developments by greatly expanding their capacity in the New ... in the pharmaceutical industry, specifically the growing demand for biologics. Biologics, which are ...
... ... announced today it has acquired Canterbury International, a privately-held company based ... furnishings. The Verdin Company, based in Cincinnati, Ohio, is recognized ... and clock towers, glockenspiels, and other musical instruments.,Canterbury International, a leading ...
... ... and Profitability. , ... Manasquan, NJ, USA (PRWEB) June 21, 2010 -- Marketers with sufficient insight to estimate ... untapped profit potential, according to the 2010 Lenskold Group / emedia Lead ...
... ... industry. Anyone who can understand this contradiction, will understand the sense of urgency related to ... now, keeping BP’s oil spill and the effects of it in mind. , ... (PRWEB) June 20, 2010 -- BP’s oil ...
... ... profession will come together to share knowledge and explore innovations in one of the most ... ... unique conferences offering high-quality scientific programs, which broaden perspectives by exploring the latest innovations in ...
Cached Medicine News:Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 2Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 3Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 4Health News:Almac's US Headquarters Will Address Capacity Demand for Clinical Supplies 2Health News:The Verdin Company Acquires Canterbury International, an industry leader in architectural site furnishings for over 50 years 2Health News:The Verdin Company Acquires Canterbury International, an industry leader in architectural site furnishings for over 50 years 3Health News:Lead Generation Marketing ROI Study Released 2Health News:Lead Generation Marketing ROI Study Released 3Health News:Lead Generation Marketing ROI Study Released 4Health News:Wind turbines harmful for the environment and public health 2Health News:The 2nd Future Trends in Implantology International Dental Conference 2
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
10 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
Avant E-Z Rack Premium Low Binding 10 l Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone....
Medicine Products: